Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Oral tazarotene improves quality of life
Washington - A new study shows that oral tazarotene (Tazorac; Allergan Inc., Irvine,Calif.) provides significant improvements in quality of life for sufferers of plaque psoriasis. The same study also illustrates the validity of a new measuring tool, PQOL (Psoriasis Quality of Life)-12, for measuring the disease's severity (see related article on Page 35).
Recent Videos
Related Content
